AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
American Geriatrics Society
7 episodes
1 week ago
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
All content for AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast is the property of American Geriatrics Society and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
Evidence Review of FDA-Approved Monoclonal Antibody Treatments
AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
23 minutes
4 weeks ago
Evidence Review of FDA-Approved Monoclonal Antibody Treatments
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Eric Widera of Professor of Clinical Medicine, Division of Geriatrics at UCSF and the Director of Hospice & Palliative Care at San Francisco VA Medical Center who, co-authored the module titled Evidence Review of FDA-Approved Monoclonal Antibody Treatments along with Kaitlin Willham, MD, Outpatient Geriatrics Clinic Medical Director at the San Francisco VA and Associate Professor of...
AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
